Susan Morrison - 15 Feb 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Signature
/s/ Rachel Malina, Attorney-in-Fact for Susan M. Morrison
Issuer symbol
TNDM
Transactions as of
15 Feb 2024
Net transactions value
-$5,295
Form type
4
Filing time
20 Feb 2024, 19:28:17 UTC
Previous filing
29 Nov 2023
Next filing
29 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +163 +1.1% $0.000000 14,900 15 Feb 2024 Direct
transaction TNDM Common Stock Tax liability $1,360 -56 -0.38% $24.29 14,844 15 Feb 2024 Direct F1
transaction TNDM Common Stock Options Exercise $0 +475 +3.2% $0.000000 15,319 15 Feb 2024 Direct
transaction TNDM Common Stock Tax liability $3,935 -162 -1.1% $24.29 15,157 15 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -163 -17% $0.000000 812 15 Feb 2024 Common Stock 163 Direct F2, F3, F4
transaction TNDM Restricted Stock Unit Options Exercise $0 -475 -17% $0.000000 2,371 15 Feb 2024 Common Stock 475 Direct F3, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F5 Awarded on May 25, 2022 pursuant to the 2013 Plan.
F6 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.